| Bioactivity | GSK264220A is a potent endothelial lipase inhibitor with IC50 of 16 nM. GSK264220A has the potential to decrease the risk of cardiovascular disease[1]. | |||||||||
| Name | GSK264220A | |||||||||
| CAS | 685506-42-7 | |||||||||
| Formula | C17H21N3O4S | |||||||||
| Molar Mass | 363.43 | |||||||||
| Appearance | Solid | |||||||||
| Transport | Room temperature in continental US; may vary elsewhere. | |||||||||
| Storage |
|
|||||||||
| Reference | [1]. Keller PM, et al. A high-throughput screen for endothelial lipase using HDL as substrate. J Biomol Screen. 2008 Jul;13(6):468-75. |
GSK264220A
CAS: 685506-42-7 F: C17H21N3O4S W: 363.43
GSK264220A is a potent endothelial lipase inhibitor with IC50 of 16 nM. GSK264220A has the potential to decrease the ris
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.